4.3 Article

Radiomics and radiogenomics of prostate cancer

Journal

ABDOMINAL RADIOLOGY
Volume 44, Issue 6, Pages 2021-2029

Publisher

SPRINGER
DOI: 10.1007/s00261-018-1660-7

Keywords

Prostate cancer; Imaging; Radiomics; Radiogenomics

Funding

  1. National Cancer Institute, National Institutes of Health [HHSN261200800001E]
  2. NIH
  3. Doris Duke Charitable Foundation
  4. American Association for Dental Research
  5. Colgate-Palmolive Company
  6. Genentech
  7. Elsevier
  8. NIH Medical Research Scholars Program
  9. NATIONAL CANCER INSTITUTE [ZIABC010655] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Radiomics and radiogenomics are attractive research topics in prostate cancer. Radiomics mainly focuses on extraction of quantitative information from medical imaging, whereas radiogenomics aims to correlate these imaging features to genomic data. The purpose of this review is to provide a brief overview summarizing recent progress in the application of radiomics-based approaches in prostate cancer and to discuss the potential role of radiogenomics in prostate cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available